This content is from: Portfolio Daily Agenda: Pessimism Reigns with Another Chinese Decline EU orders Belgium to collect unpaid corporate taxes; Shire-Baxalta merger to close; glam rocker David Bowie dead at 69. By Andrew Barber January 11, 2016
This content is from: Premium Hedge Fund Titans Bet Big on Drugmaker Shire’s Success John Paulson, Dan Loeb, and other prominent Investors move into an industry in flux. By Bailey McCann December 08, 2016
This content is from: Portfolio Daily Agenda: Bond Markets Mull September or December Fed Hike Mixed economic data from Europe; Shire makes a hostile bid for Baxalta; Neiman Marcus readies for IPO. By Andrew Barber August 05, 2015
This content is from: Premium Hedge Funds Hold Onto Last Year’s Favorites According to a new Goldman Sachs report, hedge fund firms went into the first quarter holding many of the same technology, Internet and pharmaceutical stocks that produced mixed fortunes last year. By Stephen Taub May 23, 2016
This content is from: Portfolio Daily Agenda: Scandals Rock Emerging Giants BTG Pactual CEO arrested in Brazil and another Chinese CEO goes missing; Shire to make a new bid for Baxalta; Russia turns off natural gas to Ukraine. By Andrew Barber November 25, 2015
This content is from: Portfolio Daily Agenda: Chinese Equities Drop Sharply Tensions between Saudi Arabia and Iran push oil futures higher; talk of another pharma megamerger emerges. By Andrew Barber January 04, 2016
